Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  AJR. American journal of roentgenology

• Publication date

  2008-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2214/AJR.07.2409PMID 18212199
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Free Fatty Acids Repress the GLUT4 Gene Expression in Cardiac Muscle via Novel Response Elements*

  2005cited by this paper
• Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation.

  2004cited by this paper
• Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT.

  2004cited by this paper
• Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut

  2004cited by this paper
• Non-invasive imaging in the diagnosis and management of Takayasu’s arteritis

  2004cited by this paper
• Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis.

  2003cited by this paper
• The glucose-fatty acid cycle: a physiological perspective.

  2003cited by this paper
• Imaging Atherosclerotic Plaque Inflammation With [18F]-Fluorodeoxyglucose Positron Emission Tomography

  2002cited by this paper
• Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β‐cell dysfunction

  2002cited by this paper
• 1. Positron Emission Tomography of Thoracic Malignancies. Reduction of Myocardial Fluorodeoxyglucose Uptake Artifacts With a Carbohydrate Restricted Diet.

  2000cited by this paper
• Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants.

  1999cited by this paper
• Mechanisms of fatty acid-induced inhibition of glucose uptake.

  1994cited by this paper

• Assessment of Cardiac Sarcoidosis with PET/CT

  2025cites this paper
• Gallium-Labeled PET Radiopharmaceuticals in Cardiovascular Disease

  2025cites this paper
• [18F]FDG PET/CT in cardiovascular infections: a practical approach.

  2025cites this paper
• Role of multimodality imaging in cardiac implantable electronic devices related infection and infective endocarditis

  2025cites this paper
• Can ChatGPT answer patients' questions about nuclear stress tests and 18F-Flurodeoxyglucose PET for myocardial inflammation?

  2025cites this paper
• Whole-body 18F-FDG PET/CT identifies subclinical metabolic phenotypes in normoglycemic adults

  2025cites this paper
• A novel method in myocardial injury risk stratification using intravenous fat emulsion as sole rapid preparation for unfasted patients to suppress myocardial 18F-fluorodeoxyglucose uptake for optimal cardiac PET imaging: a proof-of-concept randomized-crossover trial

  2024cites this paper
• Nuclear imaging of cardiac sarcoidosis: What's old is new again.

  2024cites this paper
• Ketogenic diet as a tool for enhancing 2-[18 F]FDG accumulation in lung adenocarcinoma with lepidic-predominant growth

  2024cites this paper
• Management of cardiac sarcoidosis.

  2024cites this paper
• The active papillary muscle sign in 18F-FDG PET/CT cardiac sarcoidosis exams and its relationship with myocardial suppression

  2024cites this paper
• Heparin does not improve myocardial glucose metabolism suppression in [18 F]FDG PET/CT in patients with low β-hydroxybutyrate level

  2024influential citation
• Atherosclerosis Imaging: Positron Emission Tomography.

  2023cites this paper
• Utility of serum ketone levels for assessment of myocardial glucose suppression for ^18F-fluorodeoxyglucose PET in patients referred for evaluation of endocarditis

  2023cites this paper
• Cardiac sarcoidosis: a comprehensive review of risk factors, pathogenesis, diagnosis, clinical manifestations, and treatment strategies

  2023cites this paper
• Robustness of [18F]FDG PET/CT radiomic analysis in the setting of drug-induced cardiotoxicity

  2023cites this paper
• Assessment of Myocardial 18F-FDG Uptake at PET/CT in Asymptomatic SARS-CoV-2-vaccinated and Nonvaccinated Patients.

  2023cites this paper
• Myocardial Inflammation at FDG PET/MRI and Clinical Outcomes in Symptomatic and Asymptomatic Participants after COVID-19 Vaccination

  2023cites this paper
• Regional brain glucose metabolism is differentially affected by ketogenic diet: a human semiquantitative positron emission tomography

  2023cites this paper
• Effective suppression of myocardial glucose uptake using predesigned low-carbohydrate boxed meals

  2022cites this paper
• The Emerging Role of FDG PET/CT in Diagnosing Endocarditis and Cardiac Device Infection.

  2022cites this paper
• Design and rationale for a comparison study of Olmesartan and Valsartan On myocardial metabolism In patients with Dilated cardiomyopathy (OVOID) trial: study protocol for a randomized controlled trial

  2022cites this paper
• Combined Cardiac Fluorodeoxyglucose-Positron Emission Tomography/Magnetic Resonance Imaging Assessment of Myocardial Injury in Patients Who Recently Recovered From COVID-19.

  2022cites this paper
• The detection of infectious endocarditis may be enhanced by a repeat FDG-PET while maintaining patients on a ketogenic diet

  2022cites this paper
• CASSIA (cardiology software suite for image analysis): a potential new tool for the evaluation of [18F]FDG PET/CT in the setting of infective endocarditis

  2022cites this paper
• Various Aspects of Fasting on the Biodistribution of Radiopharmaceuticals.

  2022cites this paper
• Role of Multimodal Imaging in Patients With Suspected Infections After the Bentall Procedure

  2021cites this paper
• 18F-FDG-Uptake in Mediastinal Lymph Nodes in Suspected Prosthetic Valve Endocarditis: Predictor or Confounder?

  2021cites this paper
• Challenges in Patient Preparation

  2021cites this paper
• Patterns of [18F]FDG myocardial uptake in oncology patients as a predictor of myocardial ischaemia on stress myocardial perfusion imaging.

  2021cites this paper
• An image processing tool for the detection of anthracycline-induced cardiotoxicity by evaluating the myocardial metabolic activity in [18F]FDG PET/CT

  2021cites this paper
• Delayed PET/CT of Pericardial Synovial Sarcoma.

  2021cites this paper
• Dynamic FDG PET Imaging to Probe for Cardiac Metabolic Remodeling in Adults Born Premature

  2021cites this paper
• Comparison of the Effect of Three Different Dietary Modifications on Myocardial Suppression in 18F-FDG PET/CT Evaluation of Patients for Suspected Cardiac Sarcoidosis

  2021cites this paper
• Associations of physiologic myocardial 18F-FDG uptake with fasting duration, HbA1c, and regular exercise

  2021cites this paper
• Sarcoid Heart Disease: Review of Current Knowledge

  2021cites this paper
• Positron emission tomography in clinically suspected myocarditis - STREAM study design.

  2021cites this paper
• PET-Based Imaging with 18F-FDG and 18F-NaF to Assess Inflammation and Microcalcification in Atherosclerosis and Other Vascular and Thrombotic Disorders

  2021cites this paper
• Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis

  2021cites this paper
• Best Practices for Imaging Cardiac Device-Related Infections and Endocarditis: A JACC: Cardiovascular Imaging Expert Panel Statement.

  2021cites this paper
• 18F-FDG PET/CT in Infective Endocarditis: Indications and Approaches for Standardization

  2021cites this paper
• Utility of Short-Acting Intravenous Insulin Therapy in Preparation of F-18 Fluorodeoxyglucose Positron Emission Tomography Computed Tomography Scan in Cancer Patients Incidentally Detected with High Blood Glucose Levels on the Day of Test

  2020cites this paper
• PET Scan with Fludeoxyglucose/Computed Tomography in Low-Grade Vascular Inflammation.

  2020cites this paper
• Infection of cardiac prosthetic valves and implantable electronic devices: early diagnosis and treatment

  2020cites this paper
• Infection and Inflammation Imaging: Beyond FDG.

  2020cites this paper
• Imaging Atherosclerosis by PET, With Emphasis on the Role of FDG and NaF as Potential Biomarkers for This Disorder

  2020cites this paper
• FDG PET/CT in low-grade Vascular Inflammation

  2020cites this paper
• Hypermetabolism of the spleen or bone marrow is an additional albeit indirect sign of infective endocarditis at FDG-PET

  2020cites this paper
• Vessel Based Imaging Techniques: Diagnosis, Treatment, and Prevention

  2020cites this paper
• Combined PET/CT with thoracic contrast-enhanced CT in assessment of primary cardiac tumors in adult patients

  2020cites this paper
• Myocardial Positron Emission Tomography for Evaluation of Cardiac Sarcoidosis: Specialized Protocols for Better Diagnosis

  2020cites this paper
• Estimation of optimal number of gates in dual gated 18F-FDG cardiac PET

  2020cites this paper
• 18F-FDG positron emission tomography/computed tomography of cardiac implantable electronic device infections

  2020cites this paper
• Improvement of diagnostic accuracy of 18fluorine-fluorodeoxyglucose PET/computed tomography in detection of infective endocarditis using a 72-h low carbs protocol

  2020cites this paper
• Assessment of Myocarditis: Cardiac MR, PET/CT, or PET/MR?

  2019cites this paper
• The role of positron emission tomography in the assessment of cardiac sarcoidosis.

  2019cites this paper
• Characterization of a highly effective preparation for suppression of myocardial glucose utilization

  2019cites this paper
• Exposure to Cold Unmasks Potential Biomarkers of Fibromyalgia Syndrome Reflecting Insufficient Sympathetic Responses to Stress

  2019cites this paper
• FDG PET-CT findings of extra-thoracic sarcoid are associated with cardiac sarcoid: A rationale for using FGD PET-CT for cardiac sarcoid evaluation

  2019cites this paper
• Electrophysiology study for risk stratification in patients with cardiac sarcoidosis and abnormal cardiac imaging

  2019cites this paper
• FDG PET/CT for Sarcoidosis

  2019cites this paper
• Advances in PET Imaging of Sarcoidosis

  2019cites this paper
• Serial Cardiac FDG-PET for the Diagnosis and Therapeutic Guidance of Patients With Cardiac Sarcoidosis.

  2019cites this paper
• Advanced Coronary Artery Vessel Wall Imaging and Future Directions

  2019cites this paper
• Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis

  2019cites this paper
• Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis—2018 update: Japanese Society of Nuclear Cardiology recommendations

  2019cites this paper
• Imaging vascular calcification

  2019cites this paper
• Cardiothoracic manifestations of Erdheim-Chester disease.

  2019cites this paper
• The value of F-18-fluorodeoxyglucose positron emission tomography ( FDG-PET / CT ) in the intensive care unit : a review

  2019cites this paper
• Effects of a Ketogenic Diet on [18F]FDG-PET Imaging in a Mouse Model of Lung Cancer

  2018cites this paper
• 18F-NaF and 18F-FDG as molecular probes in the evaluation of atherosclerosis

  2018cites this paper
• PET/MRI in Infection and Inflammation.

  2018cites this paper
• Variances of dietary preparation for suppression of physiological 18F-FDG myocardial uptake in the presence of cardiac sarcoidosis: A systematic review

  2018cites this paper
• 心臓サルコイドーシスに対する18F-FDG PET検査の手引き 2018年改訂

  2018cites this paper
• Diagnostic value of quantitative assessment of cardiac 18F-fluoro-2-deoxyglucose uptake in suspected cardiac sarcoidosis

  2018cites this paper
• A 1-week extension of a ketogenic diet provides a further decrease in myocardial 18F-FDG uptake and a high detectability of myocarditis with FDG-PET

  2018cites this paper
• Effect of prolonged fasting and low molecular weight heparin or warfarin therapies on 2-deoxy-2-[18F]-fluoro-D-glucose PET cardiac uptake

  2018cites this paper
• Novel applications of positron emission tomography in the non-invasive assessment of cardiovascular disease

  2018influential citation
• 18F-fluorodeoxyglucose use after cardiac transplant: A comparative study of suppression of physiological myocardial uptake

  2018cites this paper
• Personalizing Medicine Through Hybrid Imaging and Medical Big Data Analysis

  2018cites this paper
• Clinical use of cardiac PET/MRI: current state-of-the-art and potential future applications

  2018cites this paper
• PET/CT in Assessment of Sarcoidosis

  2018cites this paper
• 18F-FDG-PET/CT Imaging to Diagnose Septic Emboli and Mycotic Aneurysms in Patients with Endocarditis and Cardiac Device Infections

  2018cites this paper
• PET and Cardiac Infections

  2018cites this paper
• PET Imaging of Cardiac Hypoxia: Hitting Hypoxia Where It Hurts

  2018cites this paper
• The association between diabetes mellitus and reduction in myocardial glucose uptake: a population-based 18F-FDG PET/CT study

  2018cites this paper
• Positron-emission Tomography–Computed Tomography for Detection of Primary Pericardial Lymphoma

  2018cites this paper
• Hybrid cardiac imaging using PET/MRI: a joint position statement by the European Society of Cardiovascular Radiology (ESCR) and the European Association of Nuclear Medicine (EANM)

  2018cites this paper
• Hybrid cardiac imaging using PET/MRI: a joint position statement by the European Society of Cardiovascular Radiology (ESCR) and the European Association of Nuclear Medicine (EANM)

  2018cites this paper
• Current Status of Molecular Imaging in Infections.

  2018cites this paper
• A pilot study of cardiopulmonary exercise testing and cardiac stress positron emission tomography before major non‐cardiac surgery

  2018cites this paper
• The RIGHT study : Risk stratification with Image Guidance of HMG coa reductase inhibitor Therapy

  2018cites this paper
• PET/MR Imaging: Current and Emerging Applications

  2018cites this paper
• A pilot study of cardiopulmonary exercise testing and cardiac stress positron emission tomography before major nonâ•’cardiac surgery<link href='#anae14447-note-1001'></link>

  2018cites this paper
• Joint SNMMI–ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring

  2017cites this paper
• Comparison of volumetric and functional parameters in simultaneous cardiac PET/MR: feasibility of volumetric assessment with residual activity from prior PET/CT

  2017cites this paper
• Precision Medicine and PET/Computed Tomography in Cardiovascular Disorders.

  2017cites this paper
• Evaluation of a low-carbohydrate diet-based preparation protocol without fasting for cardiac PET/MR imaging

  2017cites this paper
• Table of Contents.

  2017cites this paper
• Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis

  2017cites this paper